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Abstract
Background: Near-IR fluorescence (NIRF) imaging is becoming a promising approach in preclinical tumor detection
and clinical image-guided oncological surgery. While heptamethine cyanine dye IR780 has excellent tumor targeting
and imaging potential, its hydrophobic property limits its clinical use. In this study, we developed nanoparticle formulations to facilitate the use of IR780 for fluorescent imaging of malignant brain tumor.
Methods: Self-assembled IR780-liposomes and IR780-phospholipid micelles were prepared and their NIRF properties
were characterized. The intracellular accumulation of IR780-nanoparticles in glioma cells were determined using confocal microscopy. The in vivo brain tumor targeting and NIRF imaging capacity of IR780-nanoparticles were evaluated
using U87MG glioma ectopic and orthotopic xenograft models and a spontaneous glioma mouse model driven by
RAS/RTK activation.
Results: The loading of IR780 into liposomes or phospholipid micelles was efficient. The particle diameter of IR780liposomes and IR780-phospholipid micelles were 95 and 26 nm, respectively. While stock solutions of each preparation were maintained at ready-to-use condition, the IR780-phospholipid micelles were more stable. In tissue culture
cells, IR780-nanoparticles prepared by either method accumulated in mitochondria, however, in animals the IR780phospholipid micelles showed enhanced intra-tumoral accumulation in U87MG ectopic tumors. Moreover, IR780phospholipid micelles also showed preferred intracranial tumor accumulation and potent NIRF signal intensity in
glioma orthotopic models at a real-time, non-invasive manner.
Conclusion: The IR780-phospholipid micelles demonstrated tumor-specific NIRF imaging capacity in glioma preclinical mouse models, providing great potential for clinical imaging and image-guided surgery of brain tumors.
Keywords: Near infrared fluorescence imaging, Liposomes, Phospholipid micelles, Brain tumor, Blood–brain barrier
Background
Non-invasive imaging modalities, such as computed
tomography (CT), magnetic resonance imaging (MRI),
single-photon emission computed tomography (SPECT),
and positron emission tomography (PET) play key
roles in clinical diagnosis, evaluation of disease status and treatment of tumor. The in vivo optical imaging
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technology using near-infrared fluorescent (NIRF)
probes, due to the low NIR absorption and scattering
by the tissue, and minimal tissue auto-fluorescence in
the NIR window (700–900 nm), is becoming a convenient alternative to the comprehensive imaging modalities
in preclinical studies for tumor detection [1–4] and is
showing promising results in clinical image-guided oncological surgery [5–10]. The NIRF dye indocyanine green
(ICG) has been exploited for imaging of angiogenesis
and hepatic segments after hepatectomy [5, 6], as well
as for NIR image-guided surgery in a few cancer types
[7]. Methylene blue (MB) showed good potential to aid
pancreatic tumor resection [8]. Both dyes are approved
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for clinical use [9, 10]. Among other dyes, NIRF heptamethine cyanine dye IR780 was found to have excellent
intrinsic tumor targeting and imaging properties without
further modification [11–14], providing great potential
for tumor NIRF imaging. IR780′s low cytotoxicity makes
it of potential clinical use; however, it is also hydrophobic
and insoluble in pharmaceutically acceptable solvents,
thus an appropriate formulation is required for clinical use [15, 16]. Several formulations of IR780-encapsulated nanoparticles have been investigated, such as the
heparin-folic acid conjugate [17], biodegradable human
serum albumin nanoparticles [15], transferrin nanoparticles [16], poly(n-butyl cyanoacrylate) nanocapsules
[18], poly(styrene-alt-maleic anhydride)-based diblock
copolymer micelles [19], rhenium-188 labeled methoxy poly(ethylene glycol)-block-poly(ε-caprolactone)
copolymeric micelles [20], pH-responsive polymeric
prodrug micelles [21], phospholipid mimicking homopolymeric micelles [22], bubble-generating folate-targeted
liposomes [23], and amsacrine analog-loaded solid lipid
nanoparticle [24]. However, most of these carriers were
designed for both diagnostic and therapeutic purpose,
rarely for fulfilling the unique requirement of NIRF imaging or tumor detection.
Glioblastoma multiforme (GBM) is the most common and lethal primary brain tumor lacking effective
therapeutics due to the invasive growth. The migratory
tumor cells penetrate into normal parenchyma preventing its complete surgical removal, and its high resistance to chemotherapy and radiotherapy contribute to
GBM’s recurrence as a more invasive phenotype [25, 26].
Although it is well established that the degree of surgical
resection directly correlated to patient survival [27, 28],
most surgery is performed based on the surgeon’s direct
visualization of the tumor without any image guidance.
Blood–brain barrier (BBB) and blood–tumor barrier
(BTB) further challenge the effective treatment of this
brain tumor, as most chemotherapy reagents fail to benefit the patients due to the lack of penetration into tumor
tissue [29, 30]. NIRF imaging is expected to benefit the
preclinical study of GBM and the optical image-guided
surgery. Phospholipid nanoparticles, including liposomes
and phospholipid micelles are promising drug carriers,
which are biocompatible and able to improve the pharmacokinetics of the encapsulated drug and accumulation in a solid tumor via the enhanced permeability and
retention (EPR) effect [31–33] In this study, we generated
two formulations, liposomes and phospholipid micelles
(Schematic diagram in Fig. 1) to incorporate IR780
for in vivo brain tumor imaging using both the human
GBM xenograft model and the spontaneous mouse
GBM model. The goal was to develop an appropriate
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formulation of IR780 for pharmaceutically acceptable use
for clinical imaging and brain tumor detection.

Methods
Chemical and material

1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) and
N-(carbonyl-methoxypolyethyleneglycol 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine sodium salt
(DSPE-PEG2000) were purchased from NOF America Corporation. Cholesterol, IR780 iodide and other
chemicals were purchased from Sigma-Aldrich. Hoechst
33,342, MitoTracker were purchased from Molecular
Probes.
Cell lines and culture

U87MG human glioma cells were from American Type
Culture Collection (ATCC, Manassas, VA). U87M2/luc
cells were derived from U87MG that stably overexpress
firefly luciferase [34]. T98G human glioblastoma cells
were from ATCC. All cell lines were grown in DMEM
(invitrogen, CA) supplemented with 10% fetal bovine
serum (FBS) (Hyclone, UT), 1% penicillin, and 1% streptomycin (invitrogen).
Preparation of IR780‑liposomes and IR780‑phospholipid
micelles

For IR780-liposome preparation, DSPC, cholesterol and
DSPE-PEG2000 at a molar ratio of 54.8:40:5 were dissolved in chloroform (about 15 mg total lipids/ml); 1 mg/
ml IR780 iodide in ethanol then was added to final 0.2%
molar ratio of dye to total lipids. The solution was rotary
evaporated in the dark to dryness in vacuo. The dried
lipid film was hydrated in nitrogen gas-flushed 0.9%
saline to a final total lipid concentration of 30 mM, vortexed and ultra-sonicated under a nitrogen atmosphere
for final suspension of the lipid particles. The suspension was repeatedly extruded 16 times through a 100 nm
Whatman Nucleopore track-etched polycarbonate membrane at 56 °C. The acquired clear bluish suspension was
flushed with nitrogen gas, sealed in a glass vial and stored
at either 4 or −20 °C in the dark.
To prepare IR780-phospholipid micelles, thin lipid
film composed of DSPC and DSPE-PEG2000 containing
IR780 (molar ratio, 59.5:40:0.5) was formed in the same
way as for the liposomes preparation, then hydrated with
nitrogen gas-flushed 0.9% saline to a final total lipid concentration of 15 mM, vortexed and ultra-sonicated at
56 °C for 15 min under a nitrogen gas atmosphere, and
extruded through a 100 nm Whatman Nucleopore tracketched polycarbonate membrane. The acquired clear
cyan micelle suspension was stored under the same conditions as the liposomes.

Li et al. J Transl Med (2017) 15:18
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Fig. 1 Chemical structure of IR780 and schematic diagram of IR780-liposomes and phospholipid micelles. Phospholipid nanoparticles, including
liposomes and micelles are promising drug carriers, which can improve the pharmacokinetic property of the encapsulated drug and its accumulation and retention in solid tumor via the enhanced intratumoral permeability. The liposomes vesicle is composed of a phospholipid bilayer
membrane enclosing an aqueous compartment. The phospholipid micelle vesicle has a single layer of phospholipid core with hydrophilic PEG
chain coating on the surface. The sizes of phospholipid micelles are generally smaller than liposomes. Hydrophobic IR780 can self-assemble into the
phospholipid bilayer membrane of liposomes and the phospholipid core of micelles during the formation of IR780-nanoparticles

Characterization of IR780‑liposomes
and IR780‑phospholipid micelles
Particle sizing of IR780‑liposomes and IR780‑phospholipid
micelles

The particle size distributions of IR780-liposomes and
IR780-phospholipid micelles were measured with a
DynaPro dynamic light-scattering system (Wyatt Technology, CA). Before measurement, the samples were
diluted with 200 nm membrane-filtered saline to reach
appropriate signal concentrations.
Near infrared absorption and fluorescence spectra
of IR780‑liposomes and IR780‑phospholipid micelles

Visible absorption spectra of IR780, IR780-liposomes and
IR780-phospholipid micelles diluted in PBS, ethanol/PBS
and PBS/FBS mixtures were measured by a preconfigured UV–visible spectrometer (StellarNet, Inc., FL). The
near infrared fluorescent spectra were measured using a
Synergy™ Neo HTS Multi-mode microplate reader (BioTek, VT).

Stability of IR780‑liposomes and IR780‑phospholipid micelles

IR780-liposomes and IR780-phospholipid micelles
were aliquoted as stock solution (20×) and kept in the
dark at 4 or −20 °C. At different time points the aliquots were equilibrated at room temperature and further diluted with PBS into a working solution (1×). The
NIR fluorescent signal intensity was measured at Ex/
Em = 745/815 nm. The stability was determined using
relative fluorescent intensity (FI/FI0) which was measured by fluorescent signal intensity of samples stored at
4 °C (FI) as compared with those stored at −20 °C (FI0).
In vitro cellular uptake of IR780‑liposomes
and IR780‑phospholipid micelles

T98G and U87MG cells were pre-cultured in a flask with
DMEM medium supplied with 10% FBS at 37 °C with 5%
CO2. For cellular uptake experiments, cells were trypsinized and re-seeded on glass coverslips at a density
of 6 × 104/cm2 and cultured for another 24 h to reach
60–80% confluency; the medium was replaced with fresh
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medium supplied with free IR780 (IR780 stock solution
in ethanol freshly diluted in PBS), IR780-liposomes or
IR780-phospholipid micelles with the final IR780 concentration at 1 μM IR780. After 30 min of incubation, the
cells were washed twice with PBS and supplied with fresh
DMEM medium without phenol red followed by further staining with Hoechst 33,342 (10 μg/ml) for 1 h and
MitoTracker (1 nM) for 10 min. Microscopic images of
cells washed with cold PBS and then supplemented with
medium were acquired using a confocal laser scanning
microscope (Nikon A1 Plus-RSi, Japan). The excitation/
emission wavelengths for fluorescent imaging of Hoechst
33,342, IR780 and Mitotracker were 350/461, 650/780
and 554/576 nm, respectively.
GBM tumor models

All studies involve animals were approved by the VARI
Institutional Animal Care and Use Committee (IACUC).
To establish U87M2/luc ectopic xenograft tumor model,
5 × 105 cells in 100 μl of PBS were subcutaneously inoculated into the flank region of 6-week old nude mice to
initiate tumor growth. Three weeks after inoculation,
tumor initiation rate reached 90%. Tumor size was measured twice a week using a caliper with tumor volume
(mm3) = width2 × length/2. The ability of IR780-nanoparticles to cross the BBB was tested using the U87M2/
luc orthotopic model as previously described [34].
Briefly, mice were inoculated using a stereotaxic frame.
A burr hole was created through the skull 2 mm posterior to the bregma, 2 mm anterior to the central suture,
and 3 mm below the meninges; U87M2/luc cells (5 × 105
cells in 5 μl of PBS) were injected into the brain parenchyma. The orthotopic tumor growth was measured
by bioluminescence signal intensity (BLI). Each mouse
received an intraperitoneal injection of 100 μl of 30 mg/
ml D-luciferin sodium solution, and images were taken
after 10 min using an AMI1000 optical imager (Spectral Instruments Imaging, Inc., Tucson, AZ). To induce
mouse glioma, plasmids pT2/C-Luc/PGK-SB100, pT/
CAGGS-NRASV12, pKT2/CLP-AKT, and pT2/shP53/
GFP4 (provided by Dr. David Largaespada, University of
Minnesota) were mixed and the intracerebroventricular
injection was performed as previously described [35].
In brief, neonatal mice were placed on ice for 4 min to
induce anesthesia before being secured in a cooled,
“neonatal rat” stereotaxic frame (Stoelting, IL) maintained at 4–8 °C by a dry ice/ethanol reservoir. A 10 μl
syringe fitted with a 30 gauge hypodermic needle (12.5°
bevel; Hamilton, NV) attached to an automatic injector
(Stoelting, IL) was used to inject plasmids at a flow rate of
0.7 μl/min into the right lateral cerebral ventricle. A total
of 2 μg of plasmid DNA (mixed at 1:1:1:1) in 2 μl was
injected into each mouse to induce spontaneous glioma.
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No incision was made for the injection. The skull of a
neonate was penetrated with the needle for all injections.
Growth of the orthotopic tumor was monitored by BLI as
described above.
NIRF imaging with IR780 incorporated nanoparticles
in GBM mouse models

Fourteen nude mice bearing U87M2/luc tumors with
volumes of 122–580 mm3 were divided into three groups
based on balanced tumor volumes: (1) free IR780 (IR780
freshly prepared in ethanol/saline (V/V, 1:9) (n = 4),
(2) IR780-liposomes, and (3) IR780-micelles (IR780liposomes or IR780-phospholipid micelles freshly diluted
in saline containing 2 nmol of IR780, n = 5). Each mouse
was intravenously injected via tail vein with 100 μl imaging agent. The sequential whole body NIRF images at
different time points (5 min, 1, 4, 24, 48, 72, and 96 h
post injection) were acquired using an AMI1000 optical
imager (Ex/Em = 745/810 nm, acquisition time: 1 s). At
two time points, 24 h and 96 h post injection of IR780
agents, bioluminescent images also were acquired (imaging acquisition time: 10 s) to determine tumor growth.
Five nude mice with four bearing U87M2/luc orthotopic
tumors and one tumor-free healthy control, and three FVB
mice bearing spontaneous GBM induced by activation of
RAS and AKT and Trp53 loss (FVB/NRAS/AKT/shP53)
[35] were used to evaluate the imaging capacity of IR780phospholipid micelles in orthotopic brain tumors. With
orthotopic tumors, each mouse was intravenously injected
with 100 μl IR780-phospholipid micelles freshly diluted in
saline containing 4 nmol of IR780 (U87M2/luc orthotopic
model) or 6 nmol of IR780 (FVB/NRAS/AKT/shP53 spontaneous tumor model). The sequential whole body images
at different time points were captured following the same
procedure performed for U87M2/luc ectopic models.
Ex vivo imaging and histological staining

At the end of the in vivo imaging, mice bearing tumors
were sacrificed, and brain, heart, lung, liver, spleen, stomach, intestine, normal muscle and skin from lumbar were
dissected for immediate fluorescent photography using
the AMI1000 optical imager. For histology analysis, mice
brains were harvested and fixed in 10% neutral-buffered
formalin and embedded into paraffin blocks and slides
(20 μm) were cut for H&E staining. For microscopic
NIRF images, additional brain sections were cut from the
paraffin blocks. Unstained slides were scanned using the
Odyssey imager (LI-COR Biosciences) and software suite
version 3. Settings were optimized for the highest resolution and power to allow for visualization of both the fluorescent target and non-fluorescent anatomy. Resolution
was set to 21 microns with no focal offset and excitation
intensity was set to 6.0 for the 800 nm channel only.

Li et al. J Transl Med (2017) 15:18
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IR780-liposomes and 793 nm for IR780-phospholipid
micelles (Additional file 1: Figure S2). Adding ethanol to
IR780-liposomes or IR780-phospholipid micelles resulted
in maximal NIR absorption shifted to 783 nm, indicating the release of IR780 from dissolved nanoparticles.
Both IR780-liposomes and IR780-phospholipid micelles
showed broad NIR fluorescent spectrum with maximum
excitation/emission wavelength at 745/815 nm. (Additional file 1: Figure S3).
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Fig. 2 Relative fluorescent intensity of IR780-liposomes and IR780phospholipid micelles. FI/FI0 was measured by fluorescence signal
intensity of samples stored in the dark at 4 °C as compared with those
stored in the dark at −20 °C (n = 3, Ex/Em = 745/815 nm). Short bar
refers to standard deviation

Statistical analysis

All experimental data were shown as mean ± SD unless
stated otherwise. Comparisons of data between 2 groups
or among 3 groups were analyzed using independentsamples t test or one-way analysis of variance (ANOVA)
at P < 0.05.

Results
Particle sizes of IR780‑liposomes and IR780‑phospholipid
micelles

The hydrodynamic diameter of freshly prepared IR780liposomes was 95.1 ± 2.2 nm with a polydispersion index
(PI) = 0.078. The hydrodynamic diameter of freshly prepared IR780-phospholipid micelles was 26.4 ± 8.2 nm
with PI = 0.096 (Additional file 1: Figure S1). The average
particle size of IR780-liposomes and IR780-phospholipid
micelles were not significantly changed after stored at
4 °C in dark over a period of 40 days.
NIR absorption and fluorescence properties
of IR780‑liposomes and IR780‑phospholipid micelles

The maximum NIR absorption wavelength of IR780
in ethanol was at 783 nm (Additional file 1: Figure S2).
Dilution of the IR780 stock solution with water resulted
in the hypochromatic shift of the absorption band and
decreased absorbance, probably due to IR780 aggregation or the molecular stacking of aromatic ring structure
in aqueous solution, which can be reversed by adding
ethanol. The insertion of IR780 into liposomes or phospholipid micelles caused the bathochromic shift of the
absorption band and decreased absorbance (791 nm for

The long term stability of IR780-liposomes and IR780phospholipid micelles was evaluated using fluorescence
signal intensity of samples stored at 4 °C (FI) as compared
with that stored at −20 °C (FI0) in dark (Fig. 2). While
both IR780-liposomes and IR780-phospholipid micelles
showed constant FI0 over the 40-day period, IR780liposomes showed decreased FI with time, resulting in a
significant reduced FI/FI0 = 0.69 at day 40. In contrast,
IR780-phospholipid micelles showed stable FI/FI0 = 1.0
during the entire 40 days, demonstrating their superior
stability as compared with IR780-liposomes.
In vitro cellular uptake of IR780‑liposomes
and IR780‑phospholipid micelles

We first compared intracellular uptake of free IR780,
IR780-liposomes, and IR780-phospholipid micelles
using T98G cells (Fig. 3). All three formulations showed
the same perinuclear cytoplasmic accumulation after a
30-min incubation with the cells, and also suggested a
mitochondrial localization (Fig. 3a). To confirm, T98G
and U87MG cells cultured with IR780-micelles also were
dual-stained with Mitotracker (a specific mitochondrial
marker) and Hoechst 33,342 (a specific nuclear marker)
followed by confocol microscopy (Fig. 3b). We observed
strong overlapping signals of IR780-micelles and
Mitotracker (Fig. 3b, merged), indicating a mitochondrial
accumulation of IR780-micelles, which is consistent to
previous reports that preferential accumulation of free
IR780 dye and liposomal IR780 were found in mitochondria of multiple tumor cells [11, 12, 36]. Therefore, the
incorporation of IR780 with liposomes or phospholipid
micelles preserved the same mitochondrial retention feature as free IR780.
Preferential uptake and retention of IR780‑nanoparticles
in U87M2/luc ectopic tumors

The in vivo tumor-specific uptake of free IR780, IR780liposomes, and IR780-phospholipid micelles were
evaluated using the U87M2/luc ectopic tumor model
(Fig. 4). The tumors were barely visualized at 4 h post
drug administration, however, were clearly delineated at
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Fig. 3 Mitochondrial localization of IR780 by confocal microscopy. a T98G cells were cultured with different formulations of IR780 for 30 min followed by Hoechst 33342 staining. b T98G and U87MG cells cultured with different formulations of IR780 and dual-stained with Hoechst33342 and
MitoTracker

24–120 h in all three groups. The tumors from IR780phospholipid micelles group showed stronger NIRF signals than those from IR780-liposomes and free IR780
groups, both of which displayed similar NIRF intensities
at each time point (Additional file 1: Figure S4), demonstrating that phospholipid micelle encapsulation is the
best formulation for IR780 for tumor-specific targeting
and retention.
The ex vivo NIRF images taken after the mice were
euthanized at the end of day 5 further confirmed the

major accumulation of IR780 in tumors regardless of formulation (Additional file 1: Figure S5). Minor accumulation of IR780 was found in liver, lung, skin and kidneys.
Real‑time NIRF imaging with IR780‑phospholipid micelles
in GBM orthotopic models

The blood–brain barrier is a natural challenge for drug
delivery to brain tumors. Because IR780-micelles showed
the best intratumoral uptake, we further evaluated its
NIRF imaging capacity using the U87M2/luc orthotpic

Li et al. J Transl Med (2017) 15:18
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Fig. 4 In vivo NIRF imaging of IR780-nanoparticles with U87M2/luc ectopic model. Nude mice bearing U87MG subcutaneous tumors of similar
size were dosed with free IR780, IR780-liposomes, or IR780-phospholipid micelles via tail vein injection. Post injection, sequential NIRF images were
taken at each time point as indicated using the AMI1000 optical imager at Ex/Em = 745/810 nm

model (Fig. 5). After tumor growth was confirmed by bioluminescent imaging, IR780-phospholipid micelles were
injected via tail vein and NIRF images were acquired
every 24 h for 4 days. Strong fluorescent signal intensity
with high contrast was observed in mice brain 24 h post
injection and lasted for at least 4 days, in the same area
where emitting the bioluminescent signal, demonstrating
a good intracranial tumor accumulation and retention.
In contrast, the healthy control mouse did not show significant NIRF signal in normal brain. The tumor-specific
targeting of IR780-micelles was further confirmed by the
ex vivo imaging with dissected brains and other organs at

time of necropsy (Fig. 5b, c). The NIRF signal was mainly
concentrated in the brain tumors rather than surrounding normal tissues. Compared to tumor-bearing brain,
skin and kidneys had minor retention of the dye, and
other dissected organs only showed faint signals, indicating a low retention of IR780-phospholipid micelles
(Fig. 5c).
GBM is the most malignant brain tumor due to the
extensive invasiveness; activation of RAS and AKT via
receptor tyrosine kinases (RTK) pathways frequently
occurs in GBM patients [37]. With the Sleeping Beauty
transposon system, Wiesner et al. demonstrated that

Li et al. J Transl Med (2017) 15:18
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Fig. 5 In vivo NIRF imaging of IR780-phospholipid micelles with the U87M2/luc orthotopic model. a Nude mice bearing U87M2/luc orthotopic
tumors were dosed with IR780-phospholipid micelles via tail vein injection. Post injection, sequential BLI and NIRF images were taken at each time
point as indicated using the AMI1000 optical imager at Ex/Em = 745/810 nm. Note that the healthy control mouse (the 1st one on the left) did not
show any signals. b NIRF image of dissected mouse brains after the last whole body imaging. c Representative NIRF image of dissected brain and
other organs from a mouse bearing U87M2/luc orthotopic tumor. Upper brain, lung, heart and liver; Middle spleen, kidneys, stomach and intestines;
Lower muscle, skin

dysregulation of the RAS/RTK pathway induced spontaneous GBM formation in mouse; embedding luciferase as a reporter gene further allows tumor growth be
monitored using BLI [35]. We therefore also tested the
NIRF imaging capacity of IR780-phospholipid micelles
using this mouse model. We show that overexpression
of NRAS and AKT induced invasive tumor growth as
reported previously (Fig. 6a–c) [35]. Abnormal vasculature (Fig. 6d) and anaplastic cell division (Fig. 6d arrows
and insert) were also observed, indicating a fast growing
phenotype. From the same mouse, a 6-day consecutive
bioluminescent and fluorescent imaging was acquired
after IR780-phospholipid micelles were injected through
tail vein (Fig. 6e, f ). We show that the NIRF signal with
high contrast started to show up in the brain on day 2,
gradually reached peak on day 4, followed by remission thereafter until the animal was euthanized on day 6
(Fig. 6e). From the side view at day 3, the fluorescent and
bioluminescent imaging clearly showed co-localization
of the signals (Fig. 6f ), demonstrating a tumor-specific

accumulation and retention of IR780-phospholipid
micelles. Consistent to the in vivo imaging results, NIRF
imaging of brain sections using un-stained paraffin slides
showed strong fluorescent signal intensity enriched in
tumor area (Fig. 6b), supporting that IR780-phospholipid micelles can penetrate BBB and accumulate in brain
tumors.

Discussion
Molecular imaging focuses on the noninvasive quantitation and real-time visualization of molecular processes
as they occur in vivo, and NIRF imaging is becoming
an attractive approach for tumor detection in preclinical animal studies and image-guided resection in clinical oncological surgery. The hydrophobic IR780 iodide
is a promising tumor-specific targeting NIRF probe
[12, 13, 38]. Because IR780 is a weak positively-charged
lipophilic molecule, we envisioned it to intimately interact with the weak anionic phosphate moiety of phospholipid and therefore can be stably packaged within

Li et al. J Transl Med (2017) 15:18

Fig. 6 Real-time NIRF imaging of IR780-phospholipid micelles using
the GBM spontaneous mouse model. a Representative GBM tumor
section showing invasive tumor growth in H&E staining. b A duplicate
unstained brain section showing tumor targeting of IR780-phospholipid micelles by NIRF microscopic imaging. GBM hallmarks including
invasive tumor growth penetrating into normal brain (c), and anaplastic nuclear (arrowed yellow and insert) and glomeruloid body-like
vascular structure (arrowed red, d). e Whole-body bioluminescent
and NIRF imaging of a tumor-bearing mouse at different times post
injection of IR780-phospholipid micelles. f Intratumoral accumulation of IR780-micelles at day 3 post injection as imaged in the lateral
position. Note that bioluminescence and fluorescence signals come
from same area

the phospholipid nanoparticles (Fig. 1) during their
self-assembled formation. To develop an appropriate
formulation for biomedical use of IR780, we formulated IR780-liposomes and phospholipid micelles each
carrying 0.2 molar % and 0.5 molar % of IR780. Higher
molar ratios of dye were avoided to prevent the severe
fluorescent quenching upon aggregation of dye inside
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the nanoparticles. Both preparations were homogeneously dispersed suspensions and showed narrow particle
size distribution; the particle size of IR780-phospholipid micelles was much smaller than IR780-liposomes
(26.4 ± 8.2 versus 95.1 ± 2.2 nm), indicating a better
potential to cross the BBB and BTB. Notably, the insertion of lipophilic IR780 into liposomes or phospholipid micelles reached 100% during the preparation
and required no further purification step. Comparing
with IR780-liposomes, which gradually lost NIRF signal intensity over time, IR780-micelles were very stable,
and therefore, encapsulation into micelles is a better formulation for IR780. In addition to phospholipids, cholesterol also serves as a major lipid component which
facilitates the liquid-ordered structures and stabilizes
the bilayer of the liposome structure [39, 40]. We therefore tested the compatibility of free IR780 dye with the
phospholipid and cholesterol in aqueous suspension,
respectively. While DSPC strongly adsorbed free IR780
from aqueous suspension after severe vortexing and
centrifugation, cholesterol showed no adsorption ability
with free IR780. This incompatibility of cholesterol with
IR780 may be the cause of the lower stability of IR780liposomes compared to IR780-micelles.
GBM is the most devastating brain tumor invading
normal brain tissue and escaping surgical eradication;
most chemotherapeutic reagents lack of permeability
across the BBB and BTB, further limiting the options of
effective therapeutics. Developing nanoparticle-incorporated NIRF dyes not only may improve the brain tumor
imaging for tumor detection, but also can aid GBM surgery in the operation room to define the invasive boarder.
Among the NIRF probes that are under development,
ICG and MB are FDA approved for clinical use, although
both are blood pool agents that are not specific for any
tumor tissue [3]. In contrast, IR780 has intrinsic tumortargeting activity [13, 14, 41], and the potential to work
as a sonosensitizer for sonodynamic therapy in cancer,
suggesting its dual-role as both an imaging probe and an
anti-cancer reagent [42]. Using T98G and U87MG cells,
we demonstrate that IR780-liposomes and IR780-phospholipid micelles acted the same as free IR780 that mechanistically functions through mitochondrial (Fig. 3). The
5-day NIRF imaging using the U87M2/luc ectopic model
further verified the preferential uptake and accumulation
of IR780-liposomes and IR780-phospholipid micelles
in brain tumor, where the micelles displayed relatively
stronger IR780 intratumoral accumulation and retention. Moreover, no significant uptake and accumulation
of IR780-phospholipid micelles was observed in brain tissues from normal (Fig. 5 and Additional file 1: Figure S6)
or ectopic tumor-bearing mice Fig. (4), indicating normal
brain is not a targeting organ of IR780.

Li et al. J Transl Med (2017) 15:18

While the BBB is a natural challenge for drug delivery to brain tumors, our results show that IR780-phospholipid micelles could efficiently reach U87M2/luc
orthotopic tumors 24 h post injection. Potent fluorescent signal intensity was found mainly at the tumor area,
indicating a specific tumor targeting and accumulation
(Fig. 5). The NIRF imaging with the spontaneous GBM
mouse model (Fig. 6) showed consistent results to that
with the U87M2/luc orthotopic model, further demonstrating that IR780-phospholipid micelles could penetrate the BBB and BTB in targeting invasive GBM.
While the results from our preclinical studies have demonstrated that IR780-phospholipid micelles, combining
the passive tumor targeting feature of nanoparticles via
EPR effect [33] and the intrinsic tumor-targeting feature of
IR780, is a promising candidate nanomedicine for tumor
imaging and image-guided surgery, there are also challenges prevent its clinical translation. Compared to UV
and visible light, NIR light has its advantage by deep penetration in biological tissues, however, the skin penetration remains a major challenge. Recent studies suggest that
NIRF may penetrate skin, but the optical NIRF signal can
be affected by the different skin components [43, 44]. With
ICG, a NIRF dye shares similar optical property to IR780,
the depth of penetration for NIR fluorescence is estimated
to be between 2 and 4 cm and could be improved if the
noise floor of devices could be reduced [45]. Thus, NIRF
imaging using IR780-micelles will have similar limitations
for detecting glioma and other types of cancer, whereas
further studies addressing NIRF light absorption, scattering, transmission and reflection in context of different skin
components are required to improve its clinical translation. Developing NIRF instrumentations with optimized
light source and detectors can further enhance the capacity of NIRF as a non-invasive imaging modality in clinics.
Unlike mouse skull, human skull is more solid and tumors
are more in depth. As IR780 is expected to have limitation
in penetration through the skull, it will not be a good clinical option for non-invasively imaging brain tumor patients,
although it remains a valuable tool for imaging pre-clinical
intracranial tumor models. However, such a disadvantage does not reduce its potential value to facilitate invasive tumor imaging and clinical image-guided oncological
surgery. NIRF imaging can be used to indicate invasive
margin during brain tumor resection, or to identify local
invasion and metastatic lesions for other types of cancer.

Conclusion
In summary, we prepared IR780 carrying liposomes and
phospholipid micelles and investigated their potential as
biomedically acceptable agents for brain tumor imaging.
The IR780-phospholipid micelles were more stable than
the IR780-liposomes. Both nanoparticles showed good
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NIRF imaging with the GBM ectopic xenograft model.
Moreover, the IR780-phospholipid micelles also showed
preferential uptake in the human GBM orthotopic mouse
model and the spontaneous mouse GBM model, demonstrating good preclinical and clinical potential for sensitively imaging brain tumors and other types of cancer. In
the future, it is worthwhile to further explore the NIRF
imaging capacity of IR780-phospholipid micelles in
detecting small and early stage tumors in different cancer
types, by which individual mouse bearing small ectopic
and orthotopic tumors are to be imaged for evaluation.

Additional file
Additional file 1. Figure S1. Histograms of the hydrodynamic size
distributions of IR780 encapsulated nanoparticles. Figure S2. NIR
absorption spectra of IR780, IR780-liposomes and IR780-phospholipid
micelles. Figure S3. NIR fluorescent spectra of IR780-liposomes and
IR780-phospholipid micelles. Figure S4. In vivo NIRF signal intensity of
IR780-nanoparticles in U87MG ectopic tumors. Figure S5. Representative Ex vivo NIRF images of dissected organs from U87MG ectopic tumor
bearing mice. Figure S6. Ex vivo NIRF images of organs and tissues from
healthy control mice.
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